Erratum: Use of IMiD3, a thalidomide analog, as an adjunct to therapy for experimental tuberculous meningitis (Antimicrobial Agents and Chemotherapy (2002) 46:6 (1887-1895))

Liana Tsenova; Bande Mangaliso; George Muller; Yong Chen; Victoria H. Freedman; David Stirling; Gilla Kaplan

doi:10.1128/AAC.46.7.2313.2002

Erratum: Use of IMiD3, a thalidomide analog, as an adjunct to therapy for experimental tuberculous meningitis (Antimicrobial Agents and Chemotherapy (2002) 46:6 (1887-1895))

Liana Tsenova, Bande Mangaliso, George Muller, Yong Chen, Victoria H. Freedman, David Stirling, Gilla Kaplan

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	2313
Number of pages	1
Journal	Antimicrobial agents and chemotherapy
Volume	46
Issue number	7
DOIs	https://doi.org/10.1128/AAC.46.7.2313.2002
State	Published - 2002
Externally published	Yes

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1128/AAC.46.7.2313.2002

Cite this

Tsenova, L., Mangaliso, B., Muller, G., Chen, Y., Freedman, V. H., Stirling, D., & Kaplan, G. (2002). Erratum: Use of IMiD3, a thalidomide analog, as an adjunct to therapy for experimental tuberculous meningitis (Antimicrobial Agents and Chemotherapy (2002) 46:6 (1887-1895)). Antimicrobial agents and chemotherapy, 46(7), 2313. https://doi.org/10.1128/AAC.46.7.2313.2002

Erratum: Use of IMiD3, a thalidomide analog, as an adjunct to therapy for experimental tuberculous meningitis (Antimicrobial Agents and Chemotherapy (2002) 46:6 (1887-1895)). / Tsenova, Liana; Mangaliso, Bande; Muller, George et al.
In: Antimicrobial agents and chemotherapy, Vol. 46, No. 7, 2002, p. 2313.

Research output: Contribution to journal › Comment/debate › peer-review

Tsenova, L, Mangaliso, B, Muller, G, Chen, Y, Freedman, VH, Stirling, D & Kaplan, G 2002, 'Erratum: Use of IMiD3, a thalidomide analog, as an adjunct to therapy for experimental tuberculous meningitis (Antimicrobial Agents and Chemotherapy (2002) 46:6 (1887-1895))', Antimicrobial agents and chemotherapy, vol. 46, no. 7, pp. 2313. https://doi.org/10.1128/AAC.46.7.2313.2002

@article{6c3541334160467abba6bbc0460aa1aa,

title = "Erratum: Use of IMiD3, a thalidomide analog, as an adjunct to therapy for experimental tuberculous meningitis (Antimicrobial Agents and Chemotherapy (2002) 46:6 (1887-1895))",

author = "Liana Tsenova and Bande Mangaliso and George Muller and Yong Chen and Freedman, {Victoria H.} and David Stirling and Gilla Kaplan",

year = "2002",

doi = "10.1128/AAC.46.7.2313.2002",

language = "English (US)",

volume = "46",

pages = "2313",

journal = "Antimicrobial agents and chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "7",

}

TY - JOUR

T1 - Erratum

T2 - Use of IMiD3, a thalidomide analog, as an adjunct to therapy for experimental tuberculous meningitis (Antimicrobial Agents and Chemotherapy (2002) 46:6 (1887-1895))

AU - Tsenova, Liana

AU - Mangaliso, Bande

AU - Muller, George

AU - Chen, Yong

AU - Freedman, Victoria H.

AU - Stirling, David

AU - Kaplan, Gilla

PY - 2002

Y1 - 2002

UR - http://www.scopus.com/inward/record.url?scp=0036086947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036086947&partnerID=8YFLogxK

U2 - 10.1128/AAC.46.7.2313.2002

DO - 10.1128/AAC.46.7.2313.2002

M3 - Comment/debate

AN - SCOPUS:0036086947

SN - 0066-4804

VL - 46

SP - 2313

JO - Antimicrobial agents and chemotherapy

JF - Antimicrobial agents and chemotherapy

IS - 7

ER -

Erratum: Use of IMiD3, a thalidomide analog, as an adjunct to therapy for experimental tuberculous meningitis (Antimicrobial Agents and Chemotherapy (2002) 46:6 (1887-1895))

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this